Approval · Notice of Compliance 26083 · 2021
CUROSURF: Notice of Compliance 26083
Issued June 15, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26083
- Date
- June 15, 2021
- Company
- Chiesi Farmaceutici S.P.A.Parma, --, Italy
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New method of administration
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CUROSURF | Not yet assigned | — |
Medicinal ingredients
- PORACTANT ALFA 80 MG per ML